New diorganotin(IV) derivatives of 7-hydroxycoumarin (umbelliferone) and their adducts with 1,10-phenanthroline

New diorganotin(IV) derivatives of the general formula R2Sn(Umb)2 (where R = n-Bu, n-Oct and Ph; Umb = umbelliferone anion) have been synthesized either by the reaction of R2SnO with umbelliferone under azeotropic removal of water or by the reaction of R2SnCl2 with sodium salt of umbelliferone. Further, the adducts of the general formula R2Sn(Umb)2.phen (where R = n-Bu and n-Oct; phen = 1,10-phenanthroline) have also been synthesized by the interaction of R2Sn(Umb)2 with 1,10-phenanthroline. The bonding and coordination behavior in these derivatives are discussed on the basis of IR and 119Sn M?ssbauer spectroscopic studies in solid state. Their coordination behavior in solution is discussed by the multinuclear (1H, 13C and 119Sn) NMR spectral studies. The M?ssbauer and IR studies indicate that umbelliferone acts as a monoanionic bidentate ligand in R2Sn(Umb)2 coordinating through O(7) and O(1). A distorted octahedral geometry around tin has been proposed for R2Sn(Umb)2 as well as for R2Sn(Umb)2.phen in solid state. The newly synthesized derivatives have been tested for their anti-inflammatory and cardiovascular activities. The average LD50 value >1000 mg kg(-1) of these compounds indicates their safety margin.     

Structure‐cytotoxicity relationship for apoptotic inducers organotin(IV) derivatives of mandelic acid and L‐proline and their mixed ligand complexes having enhanced cytotoxicity

Structure‐cytotoxicity relationship of di?/tri‐organotin(IV) derivatives of mandelic acid ( 1 – 4 ), L‐proline ( 5 – 7, 15, 16 ), and mixed ligand complexes of latter with 1,10‐phenanthroline ( 8 – 14 ) investigated on the basis of MTT assay against human cancer cell lines, viz. MCF‐7 (mammary cancer), HepG2 (liver cancer) and PC‐3 (prostate cancer) in vitro indicated that all complexes except methyl‐ and octyl‐ analogues displayed potential cytotoxicity. The most active one is dibutyltin(IV) mandelate ( 2 ) exhibiting IC₅₀ 2.03 ± 0.40, 0.98 ± 0.23 and 3.86 ± 1.68 μM against MCF‐7, HepG2 and PC‐3, respectively, which is ≈ 15 and 2.5 times against MCF‐7, 20 and 5 times against HepG2 and 5 and ≈ 3 times against PC‐3 more cytotoxic than cis‐platin and 5‐fluorouracil, respectively. Diorganotin(IV) derivatives of mandelic acid are more cytotoxic than triorganotin analogues. Organotin(IV) derivatives of L‐proline (except Bu₃Sn(Pro) 16 ) are less cytotoxic than those of mandelic acid but their cytotoxicity is enhanced by complexion with 1,10‐phenanthroline. This may be due to the structural planarity and extended π system of 1,10‐phenanthroline which facilitates their transportation across the cell membrane and enhances the possibility of DNA intercalation over the planar L‐proline ring, and eventually, their DNA binding affinity so as to interfere with the cellular functions of DNA leading to apoptosis. Various biophysical experiments such as DNA fragmentation, acridine orange and comet assays, and flow cytometry assay using annexin V–fluorescein isothiocyanate (FITC) and propidium iodide (PI) have been carried out in order to ascertain their mode of action. The observed results indicated that the major cause of cancer cell death is apoptosis, but a minor role played by necrosis cannot be excluded. It is concluded on the basis of the observed results that the nature and number of organic groups bonded to tin as well as the nature of counter anions play an important role in determining the cytotoxicity of organotin(IV) compounds.     

Bis‐aroylhydrazone based on 2,2′‐bis substituted diphenylamine for synthesis of new binuclear organotin (IV) complexes: Spectroscopic characterization,crystal structures,in vitro DNA‐binding,plasmid DNA cleavage,PCR and cytotoxicity against MCF7 cell line

New dinuclear organotin (IV) complexes, Me₄Sn₂L, Ph₄Sn₂L and Bu₄Sn₂L, have been synthesized from reaction of R₂SnCl₂ (R = Me, Ph and Bu) with a 2,2′‐bis‐substituted diphenylamine arοylidene hydrazone, H₄L. The synthesized compounds were investigated by elemental analysis and infrared, ¹H‐NMR and ¹¹⁹Sn‐NMR spectroscopy. The structures of H₄L, Me₄Sn₂L and Bu₄Sn₂L were also confirmed by X‐ray crystallography. H₄L molecules adopt (E)‐configuration and keto‐tautomeric form in the solid state. In all complexes, the bis‐hydrazone acts as a tetra‐anionic ligand with two contiguous ONO tridentate domains that coordinate the two R₂Sn moieties in the enolate form. The coordination environments of both tin centers are five‐coordinate. DNA‐binding studies were performed by UV–Vis spectroscopy, and the results indicate that the synthesized compounds significantly interact with calf thymus‐DNA in the intercalative mode. The results of polymerase chain reaction assay show that all the compounds affect on amplification of DNA, and complexes are more effective than ligands. The in vitro cytotoxicity against the human breast cancer line (MCF7) was determined using the MTT assay, and H₄L and the dibutytin complex showed higher activity.     

Synthesis, crystal structure and in vitro antitumor activity of carboxylate bridged dinuclear organotin(IV) complexes

Two novel dinuclear organotin(IV) complexes [n-Bu₂Sn(imda)(H₂O)]₂·Bipy (1) and [n-Bu₂Sn(imda)(H₂O)]₂·Phen (2) [H₂imda = iminodiacetic acid, Bipy = 2,2′-bipyridine and Phen = 1,10-phenanthroline] were synthesised and characterized employing IR, ¹H, ¹³C, ¹¹⁹Sn NMR, and ¹¹⁹Sn Mössbauer spectroscopic and elemental analyses. Single crystal X-ray crystallography of 1 has confirmed that it is a binuclear Sn(IV) species formed via carboxylate bridges where each metal adopted a seven coordinate distorted pentagonal bipyramidal geometry. The iminodiacetate dianion (imda²⁻) acts as a potential tridentate [N,O,O] carboxylate bridging ligand. The packing revealed that the additional α-diimine (Bipy or Phen) does not coordinate to metal ion. However, its presence in the crystal lattice as spacer helps for the formation of a supramolecular framework by bringing the two binuclear species close enough through extensive H-bonding. The in vitro cytotoxicity of compounds 1 and 2 indicate better results than cisplatin against three tumor cell lines investigated.     

Synthesis, spectral characterization and biological studies of some organotin(IV) complexes of L-proline, trans-hydroxy-L-proline and L-glutamine

New organotin(IV) complexes of the general formula R3Sn(L) (where R=Me, n-Bu and HL=L-proline; R=Me, Ph and HL=trans-hydroxy-L-proline and L-glutamine) and R2Sn(L)2 (where R=n-Bu, Ph and HL=L-proline; R=Ph, HL=trans-hydroxy-L-proline) have been synthesized by the reaction of RnSnCl(4-n) (where n=2 or 3) with sodium salt of the amino acid (HL). n-Bu2Sn(Pro)2 was synthesized by the reaction of n-Bu2SnO with L-proline under azeotropic removal of water. The bonding and coordination behavior in these complexes have been discussed on the basis of IR and 119Sn M?ssbauer spectroscopic studies in the solid-state. Their coordination behavior in solution has been discussed with the help of multinuclear (1H, 13C and 119Sn) NMR spectral studies. The 119Sn M?ssbauer and IR studies indicate that L-proline and trans-hydroxy-L-proline show similar coordination behavior towards organotin(IV) compounds. Pentacoordinate trigonal-bipyramidal and hexacoordinate octahedral structures, respectively, have been proposed for the tri- and diorganotin(IV) complexes of L-proline and trans-hydroxy-L-proline, in which the carboxylate group acts as bidentate group. L-glutamine shows different coordination behavior towards organotin(IV) compounds, it acts as monoanionic bidentate ligand coordinating through carboxylate and amino group. The triorganotin(IV) complexes of L-glutamine have been proposed to have trigonal-bipyramidal environment around tin. The newly synthesized complexes have been tested for their antiinflammatory and cardiovascular activities. Their LD50 values are >1000 mg kg-1.     

New di- and triorganotin(IV) derivatives of tyrosinylphenylalanine as models for metal-protein interactions: Synthesis and structural characterization. Crystal structure of Me2Sn(Tyr-Phe) · MeOH

New di- and triorganotin(IV) derivatives of tyrosinylphenylalanine (H₂Tyr-Phe) with general formulae R₂Sn(Tyr-Phe) where R = Me,n-Bu, n-Oct and Ph, and R₃^′Sn(HTyr-Phe) where R^′ = Me and Ph have been synthesized. The bonding and coordination behaviour in these derivatives are discussed on the basis of FT-IR, multinuclear ¹H, ¹³C and ¹¹⁹Sn NMR and ¹¹⁹Sn Mössbauer spectroscopic studies. These investigations suggest that dipeptide in R₂Sn(Tyr-Phe) acts as dianionic tridentate coordinating through −C(O)O⁻, -NH₂ and (-CO)N⁻_peptide groups while in case of R^′₃Sn(HTyr-Phe) the ligand acts as monoanionic bidentate coordinating through -C(O)O⁻ and -NH₂, and the polyhedron around tin in R₂Sn(Tyr-Phe) and R^′₃Sn(HTyr-Phe) is a distorted trigonal-bipyramidal. It is further confirmed by the single crystal X-ray structure of Me₂Sn(Tyr-Phe) · MeOH which shows two methyl groups and peptide nitrogen (N⁻_peptide) in the equatorial positions, while the two axial positions are occupied by the carboxylic oxygen (O⁻_carboxyl) and the amino nitrogen (N_amino) atom from the same ligand molecule. One methanol molecule is also present in the asymmetric unit.     

Triorganotin(IV) derivatives of umbelliferone (7-hydroxycoumarin) and their adducts with 1,10-phenanthroline: synthesis, structural and biological studies

New triorganotin(IV) derivatives of the general formula R₃Sn(Umb) (where, R = Me, n-Bu and Ph; Umb = umbelliferone anion) have been synthesized using sodium salt method. Further, the adducts of the general formula R₃Sn(Umb) · phen (where R = Me and Ph; phen = 1,10-phenanthroline) have also been synthesized by the interaction of the triorganotin(IV) derivatives of umbelliferone with 1,10-phenanthroline. The bonding and coordination behavior of these derivatives are discussed on the basis of IR, NMR (¹H, ¹³C and ¹¹⁹Sn), and ¹¹⁹Sn Mössbauer spectroscopic studies. These investigations indicate that umbelliferone acts as a monoanionic bidentate ligand in R₃Sn(Umb) coordinating through O(7) and O(1) in the solid-state. These polymeric R₃Sn(Umb) derivatives (where R = Me and n-Bu) have been proposed to have a trans-trigonal bipyramidal geometry with the three R groups in equatorial positions, while the axial positions are occupied by a phenolic oxygen and the O(1) atom from the adjacent molecule. A pseudotetrahedral geometry has been suggested for Ph₃Sn(Umb). A distorted octahedral geometry around tin has been proposed for R₃Sn(Umb) · phen, in which umbelliferone anion acts as a monodentate ligand coordinating through phenolic oxygen O(7). The newly synthesized derivatives have been assayed for their anti-inflammatory, cardiovascular and anti-microbial activities. The average LD₅₀ values >1000 mg kg⁻¹ of these derivatives indicate their safety margin. Among all the compounds tested, Ph₃Sn(Umb) · phen has been found to show potent anti-inflammatory activity with low mammalian toxicity and mild hypotensive activity.     

Novel organotin (IV) complexes derived from 4,4′‐oxybisbenzoic acid: synthesis,structure, in vitro cytostatic activity and binding interaction with BSA

Six novel organotin (IV) complexes, [(Me₃Sn)₂(H₂O)₂L] ( 1 ), [(R₃Sn)₂L]_n (R = Me 2 , R = n‐Bu 3 ), [(Ph₃Sn)₂L] ( 4 ), [Me₂SnL]_n ( 5 ), [(Me₂Sn)₂L(μ₃‐O)]_n ( 6 ) have been designed and synthesized by the reactions of 4,4′‐oxybisbenzoic acid (H₂L) and triorganotin (IV) chloride or oxide. All the complexes have been characterized by elemental analysis, FT‐IR, NMR, ESI‐Mass, PXRD and X‐ray crystallography. The single crystal diffraction reveals that complexes 1 and 4 represent dinuclear tin monomers. Complexes 2 and 3 display 2D network structure and 2D corrugated framework respectively, which both contain tetranuclear 36‐membered macrocycles. Furthermore, 2D structures are linked into a 3D supramolecular structures through intermolecular C‐H ··· π interactions. Complex 5 shows 1D infinite helical chain and further constructs 3D ladder supramolecular architecture through additional Sn ··· O and C‐H ··· O intermolecular interactions. Complex 6 displays 1D infinite polymeric chain containing 28‐membered macrocyclic ring. Preliminarily in vitro cytostatic activity studies on cervical carcinoma cell lines (HeLa) and hepatocellular carcinoma cell lines (HepG‐2) by MTT assay for some complexes reveal that complexes 3 and 4 exhibit high cytostatic activity. Further, complexes 3 and 4 were selected to investigate interactions of bovine serum albumin (BSA) by fluorescence quenching spectra and synchronous fluorescence spectra, which indicates that the complexes could quench the intrinsic fluorescence of BSA in a static quenching process.     

Synthesis of an Iron(IV) Aqua–Oxido Complex Using Ozone as an Oxidant

The iron(IV) oxido complex [(tmc)Fe=O(OTf)]OTf with the macrocyclic ligand 1,4,8,11‐tetramethyl‐1,4,8,11‐tetraazacyclo‐tetradecane (tmc) has been synthesized using ozone as an oxidant. By adding water to this compound the complex [(H₂O)(tmc)Fe=O)](OTf)₂ could be prepared. This complex is important in regard to a better understanding of the reactivity of Fe^IV oxido complexes. Mössbauer measurements using the solid compound showed an isomer shift of δ=0.19 mm s^?1 and a quadrupole splitting ΔE_Q=1.38 mm s^?1, confirming the high‐valent Fe^IV state. DFT calculations were performed and led to an assignment of triplet spin multiplicity. Crystallographic characterization of [(H₂O)(tmc)Fe=O)](OTf)₂ as well as of starting materials [(tmc)Fe(CH₃CN)](OTf)₂ and [(tmc)Fe(OTf)]OTf together with previous results strongly suggest that [(H₂O)(tmc)Fe=O)](OTf)₂ was formed similar to the oxido–hydroxido tautomerism analogous to heme systems.     

Crystallographic report: 6‐Mercaptopurinate complex of tribenzyltin(IV), (PhCH2)3Sn(C5H3N4S)Sn(PhCH2)3OMe

The title complex displays a binuclear structure in which the geometries of tin atoms are different: one is cis‐trigonal bipyramidal (with a C₃NS donor set) and the other is trans‐trigonal bipyramidal (C₃NO). Copyright © 2004 John Wiley & Sons, Ltd.